Abstract
Colorectal cancer patients with ≤10 unresectable metastases were treated with single-fraction sub-ablative radiotherapy in addition to standard of care systemic therapy in a single-arm, open-label, multicenter, pilot study (SIRIUS) to assess feasibility and safety. Results indicate that radiotherapy combined with systemic therapy is feasible and safe in this population.
| Original language | English |
|---|---|
| Article number | 100874 |
| Pages (from-to) | 1-5 |
| Number of pages | 5 |
| Journal | Clinical and translational radiation oncology |
| Volume | 49 |
| DOIs | |
| Publication status | Published - Nov 2024 |
Keywords
- Oligometastases
- phase I
- SBRT
- Single fraction
- Systemic therapy
Fingerprint
Dive into the research topics of 'Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases: A multicenter pilot study (NCT05375708)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver